Elisabeth J. Walsby, Steven J. Coles, Steven Knapper, Alan K. Burnett. The topoisomerase II inhibitor voreloxin causes cell cycle arrest and apoptosis in myeloid leukemia cells and acts in synergy with cytarabine. Haematologica 2011;96(3):393-399; https://doi.org/10.3324/haematol.2010.032680.